Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-25T05:15:28.155Z Has data issue: false hasContentIssue false
  • English
  • Français

Haloperidol-Induced Changes in Blink Rates Correlate with Changes in BPRS Score

Published online by Cambridge University Press:  29 January 2018

Craig N. Karson ,
Llewellyn B. Bigelow ,
Joel E. Kleinman ,
Daniel R. Weinberger  and
Richard Jed Wyatt
Craig N. Karson
Affiliation:
Division of Special Mental Health, Intramural Research Program, National Institute of Mental Health, Saint Elizabeths Hospital, Washington, DC 20032, USA
Llewellyn B. Bigelow
Affiliation:
Division of Special Mental Health, Intramural Research Program, National Institute of Mental Health, Saint Elizabeths Hospital, Washington, DC 20032, USA
Joel E. Kleinman
Affiliation:
Division of Special Mental Health, Intramural Research Program, National Institute of Mental Health, Saint Elizabeths Hospital, Washington, DC 20032, USA
Daniel R. Weinberger
Affiliation:
Division of Special Mental Health, Intramural Research Program, National Institute of Mental Health, Saint Elizabeths Hospital, Washington, DC 20032, USA
Richard Jed Wyatt
Affiliation:
Division of Special Mental Health, Intramural Research Program, National Institute of Mental Health, Saint Elizabeths Hospital, Washington, DC 20032, USA
Get access Rights & Permissions [Opens in a new window]

Summary

Spontaneous eye blink rates, psychiatric symptoms and response to neuroleptic medication may all be mediated by dopamine. Fixed doses of haloperidol, a dopamine blocking agent, were administered for six weeks to 17 chronic schizophrenic patients who had been previously withdrawn from all medications. The change in blink rates caused by haloperidol corresponded to a change in the thought disturbance syndrome which measures positive symptoms (r =.48, P <.05). The relationship was particularly clear in patients with normal cerebral ventricles (r =.74, P <.01).

Type
Research Article
Information
The British Journal of Psychiatry , Volume 140 , Issue 5 , May 1982 , pp. 503 - 507
Copyright
Copyright © Royal College of Psychiatrists, 1982 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Carlsson, A. & Lindqvist, R. (1963) The effect of chlorpromazine and haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacology and Toxicology, 20, 140–4.Google Scholar
Casey, D. E., Gerlach, J. & Christenson, A. (1980) Behavioral aspects of GABA-dopamine interrelationships in the monkey. Brain Research Bulletin, 5, Suppl 2.CrossRefGoogle Scholar
Cohen, D. J., Petler, J., Young, J. G. & Shaywitz, B. A. (1980) Clonidine ameliorates Gilles de la Tourette syndrome. Archives of General Psychiatry, 37, 1350–7.Google Scholar
Creese, I., Burt, D. R. & Snyder, S. A. (1976) Dopamine binding predicts clinical and pharmacological potencies of antipsychotic drugs. Science, 192, 481–3.Google Scholar
Donnelly, E. F., Weinberger, D. R., Waldman, I. N. & Wyatt, R. J. (1980) Cognitive impairment associated with morphological brain abnormalities on computerized tomography in chronic schizophrenic patients. Journal of Nervous and Mental Disease, 168, 305–8.Google Scholar
Hall, A. (1945) The origin and purposes of blinking. British Journal of Ophthalmology, 29, 445–67.Google Scholar
Johnstone, E. C., Crow, T. J., Frith, C. D., Kreel, G. & Husbard, J. (1978a) The dementia of dementia praecox. Acta Psychiatrica Scandinavica, 57, 305–24.Google Scholar
Johnstone, E. C., Crow, T. J., Frith, C. D., Husbard, J. & Kreel, L. (1976) Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet, ii, 924–6.Google Scholar
Johnstone, E. C., Frith, C. D., Crow, T. J., Carney, M. W. P. & Price, J. S. (1978b) Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet, ii, 848–51.Google Scholar
Karson, C. N., Staub, R. Z., Kleinman, J. E. & Wyatt, R. J. (1981a) Blink rates and receptor supersensitivity. Neuropharmacology, 20, 91–3.CrossRefGoogle ScholarPubMed
Karson, C. N., Freed, W. J., Kleinman, J. E., Bigelow, L. B. & Wyatt, R. J. (1981b) Neuroleptics decrease blink rates in schizophrenic patients. Biological Psychiatry, 7, 679–82.Google Scholar
Karson, C. N., Staub, R. A., Kleinman, J. E. & Wyatt, R. J. (1981c) Drug effects on blink rates in Rhesus monkeys. Biological Psychiatry, 3, 249–54.Google Scholar
Kleinman, J. E., Weinberger, D. R., Rogol, A. D., Bigelow, L. B., Klein, S. T., Gillin, J. C. & Wyatt, R. J. (1981) Relationships between plasma prolactin concentrations and psychopathology in chronic schizophrenia. Submitted Archives of General Psychiatry. Google Scholar
Kraeplin, E. (1919) Dementia Praecox. Translated by Barclay, M. Edinburgh and Philadelphia: Livingstone.Google Scholar
Siegel, (1956) Non Parametric Statistics. New York: McGraw-Hill.Google Scholar
Spitzer, R. L., Endicott, J. & Robbins, R. (1977) Research Diagnostic Criteria (RDC) for a selected group of functional disorders. (3rd edition). New York: Biometrics Research.Google Scholar
Stevens, J. R. (1978) Blink rates: Psychosis or tardive dyskinesia? American Journal of Psychiatry, 135, 223–7.Google ScholarPubMed
Weinberger, D. R., Bigelow, L. B., Kleinman, J. E., Klein, S. T., Rosenblatt, J. R. & Wyatt, R. J. (1980a) Cerebral ventricular enlargement in chronic schizophrenia: An association with poor response to treatment. Archives of General Psychiatry, 37, 11—13.Google Scholar
Weinberger, D. R., Cannon-Spoor, E., Pokin, S. G. & Wyatt, R. J. (1980b) Premorbid adjustment and CT scan abnormalities in chronic schizophrenia. American Journal of Psychiatry, 137, 1410–13.Google Scholar
Weinberger, D. R., Torrey, F. E., Neophytides, A. N. & Wyatt, R. J. (1979) Lateral cerebral ventricular enlargement in chronic schizophrenia. Archives of General Psychiatry, 36, 735–9.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.